{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T09:18:28Z","timestamp":1713777508410},"reference-count":68,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"DOI":"10.7759\/cureus.30039","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T20:50:21Z","timestamp":1665175821000},"source":"Crossref","is-referenced-by-count":1,"title":["A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes"],"prefix":"10.7759","author":[{"given":"Vaishnavi","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok M","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Metformin: current knowledge","volume":"19","author":"Nasri H","year":"2014","unstructured":"Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. J Res Med Sci. 2014, 19:658-64.","journal-title":"J Res Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.12.8.553","article-title":"Traditional plant medicines as treatments for diabetes","volume":"12","author":"Bailey CJ","year":"1989","unstructured":"Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989, 12:553-64. 10.2337\/diacare.12.8.553","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20150497","article-title":"Repurposing metformin: an old drug with new tricks in its binding pockets","volume":"471","author":"Pryor R","year":"2015","unstructured":"Pryor R, Cabreiro F. Repurposing metformin: an old drug with new tricks in its binding pockets. Biochem J. 2015, 471:307-22. 10.1042\/BJ20150497","journal-title":"Biochem J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12473","article-title":"Metformin; a review of its history and future: from lilac to longevity","volume":"18","author":"Thomas I","year":"2017","unstructured":"Thomas I, Gregg B. Metformin; a review of its history and future: from lilac to longevity. Pediatr Diabetes. 2017, 18:10-6. 10.1111\/pedi.12473","journal-title":"Pediatr Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.21","article-title":"An update on the pharmacogenomics of metformin: progress, problems and potential","volume":"15","author":"Todd JN","year":"2014","unstructured":"Todd JN, Florez JC. An update on the pharmacogenomics of metformin: progress, problems and potential. Pharmacogenomics. 2014, 15:529-39. 10.2217\/pgs.14.21","journal-title":"Pharmacogenomics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00653","article-title":"Metformin during pregnancy: Effects on offspring development and metabolic function","volume":"11","author":"Jorquera G","year":"2020","unstructured":"Jorquera G, Echibur\u00fa B, Crisosto N, Sotomayor-Z\u00e1rate R, Maliqueo M, Cruz G. Metformin during pregnancy: Effects on offspring development and metabolic function. Front Pharmacol. 2020, 11:653. 10.3389\/fphar.2020.00653","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova I","year":"2014","unstructured":"Pernicova I, Korbonits M. Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014, 10:143-56. 10.1038\/nrendo.2013.256","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: concentrations matter","volume":"21","author":"He L","year":"2015","unstructured":"He L, Wondisford FE. Metformin action: concentrations matter. Cell Metab. 2015, 21:159-62. 10.1016\/j.cmet.2015.01.003","journal-title":"Cell Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq JP","year":"2015","unstructured":"Domecq JP, Prutsky G, Leppin A, et al.. Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015, 100:363-70. 10.1210\/jc.2014-3421","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/138161209789058101","article-title":"Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome","volume":"15","author":"Motta AB","year":"2009","unstructured":"Motta AB. Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome. Curr Pharm Des. 2009, 15:3074-7. 10.2174\/138161209789058101","journal-title":"Curr Pharm Des"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine JE","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, et al.. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011, 305:1659-68. 10.1001\/jama.2011.520","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0897190015627255","article-title":"Synergistic benefit of statin and metformin in gastrointestinal malignancies","volume":"30","author":"Nimako GK","year":"2017","unstructured":"Nimako GK, Wintrob ZA, Sulik DA, Donato JL, Ceacareanu AC. Synergistic benefit of statin and metformin in gastrointestinal malignancies. J Pharm Pract. 2017, 30:185-94. 10.1177\/0897190015627255","journal-title":"J Pharm Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19071954","article-title":"Metformin in pregnancy: mechanisms and clinical applications","volume":"19","author":"Hyer S","year":"2018","unstructured":"Hyer S, Balani J, Shehata H. Metformin in pregnancy: mechanisms and clinical applications. Int J Mol Sci. 2018, 19:10.3390\/ijms19071954","journal-title":"Int J Mol Sci"},{"key":"ref14","unstructured":"Hyperglycaemia in pregnancy (HIP) (20-49 y). prevalence of gestational diabetes mellitus (GDM). (2022). Accessed: July 31, 2022: http:\/\/diabetesatlas.org\/data\/."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17424","article-title":"Feto-maternal outcomes and treatment compliance in metformin Versus insulin-treated gestational diabetic and non-diabetic patients at the Rehman Medical Institute, Peshawar","volume":"13","author":"Anthony N","year":"2021","unstructured":"Anthony N, Ahmad A, Bibi C, et al.. Feto-maternal outcomes and treatment compliance in metformin Versus insulin-treated gestational diabetic and non-diabetic patients at the Rehman Medical Institute, Peshawar. Cureus. 2021, 13:e17424. 10.7759\/cureus.17424","journal-title":"Cureus"},{"key":"ref16","unstructured":"Gestational diabetes. (2020). Accessed. July 31, 2022: http:\/\/www.idf.org\/our-activities\/care-prevention\/gdm."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57040381","article-title":"Screening for gestational diabetes during the COVID-19 pandemic-current recommendations and their consequences","volume":"57","author":"Panaitescu AM","year":"2021","unstructured":"Panaitescu AM, Ciobanu AM, Popa M, Duta I, Gica N, Peltecu G, Veduta A. Screening for gestational diabetes during the COVID-19 pandemic-current recommendations and their consequences. Medicina (Kaunas). 2021, 57:10.3390\/medicina57040381","journal-title":"Medicina (Kaunas)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: Green-top Guideline No. 72","volume":"126","author":"Denison FC","year":"2019","unstructured":"Denison FC, Aedla NR, Keag O, Hor K, Reynolds RM, Milne A, Diamond A. Care of women with obesity in pregnancy: Green-top Guideline No. 72. BJOG. 2019, 126:e62-e106. 10.1111\/1471-0528.15386","journal-title":"BJOG"},{"key":"ref19","unstructured":"Management of diabetes. (2017). Accessed. July 25, 2022: https:\/\/www.sign.ac.uk\/assets\/sign116.pdf."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-84882-120-0","article-title":"Gestational Diabetes During and After Pregnancy","author":"Kim C","year":"2010","unstructured":"Kim C, Ferrara A. Gestational Diabetes During and After Pregnancy. Springer, London; 2010. 10.1007\/978-1-84882-120-0"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S014","article-title":"Management of diabetes in pregnancy: standards of medical care in diabetes-2020","volume":"43","year":"2020","unstructured":"Management of diabetes in pregnancy. standards of medical care in diabetes-2020. Diabetes Care. 2020, 43:S183-92. 10.2337\/dc20-S014","journal-title":"Diabetes Care"},{"key":"ref22","unstructured":"Diabetes in pregnancy. management from preconception to the postnatal period. (2015). Accessed: July 26, 2022: https:\/\/www.nice.org.uk\/guidance\/ng3."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan JA","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008, 358:2003-15. 10.1056\/NEJMoa0707193","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064585","article-title":"Metformin vs insulin in the management of gestational diabetes: a meta-analysis","volume":"8","author":"Gui J","year":"2013","unstructured":"Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2013, 8:e64585. 10.1371\/journal.pone.0064585","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015557","article-title":"Treatments for gestational diabetes: a systematic review and meta-analysis","volume":"7","author":"Farrar D","year":"2017","unstructured":"Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Lawlor DA. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017, 7:e015557. 10.1136\/bmjopen-2016-015557","journal-title":"BMJ Open"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13150","article-title":"Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis","volume":"34","author":"Butalia S","year":"2017","unstructured":"Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med. 2017, 34:27-36. 10.1111\/dme.13150","journal-title":"Diabet Med"},{"key":"ref27","unstructured":"Obesity and overweight. (2021). Accessed. July 31, 2022: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2007.00464.x","article-title":"Maternal obesity: pregnancy complications, gestational weight gain and nutrition","volume":"9","author":"Guelinckx I","year":"2008","unstructured":"Guelinckx I, Devlieger R, Beckers K, Vansant G. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev. 2008, 9:140-50. 10.1111\/j.1467-789X.2007.00464.x","journal-title":"Obes Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000506690","article-title":"Effect of lifestyle interventions in obese pregnant women on the neurocognitive development and anthropometrics of preschool children","volume":"13","author":"Braeken MA","year":"2020","unstructured":"Braeken MA, Bogaerts A. Effect of lifestyle interventions in obese pregnant women on the neurocognitive development and anthropometrics of preschool children. Obes Facts. 2020, 13:256-66. 10.1159\/000506690","journal-title":"Obes Facts"},{"key":"ref30","article-title":"Carbohydrate Metabolism in Pregnancy and the Newborn","author":"Sutherland HW","year":"1984","unstructured":"Sutherland HW, Stowers JM. Carbohydrate Metabolism in Pregnancy and the Newborn. Churchill Livingstone, London; 1984."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39049.439444.DE1","article-title":"ABC of obesity. Obesity and reproduction","volume":"333","author":"Ramsay JE","year":"2006","unstructured":"Ramsay JE, Greer I, Sattar N. ABC of obesity. Obesity and reproduction. BMJ. 2006, 333:1159-62. 10.1136\/bmj.39049.439444.DE1","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801670","article-title":"Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London","volume":"25","author":"Sebire NJ","year":"2001","unstructured":"Sebire NJ, Jolly M, Harris JP, et al.. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001, 25:1175-82. 10.1038\/sj.ijo.0801670","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.91.3.436","article-title":"Pregnancy complications and outcomes among overweight and obese nulliparous women","volume":"91","author":"Baeten JM","year":"2001","unstructured":"Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001, 91:436-40. 10.2105\/ajph.91.3.436","journal-title":"Am J Public Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00437.x","article-title":"Pre-pregnancy weight and the risk of stillbirth and neonatal death","volume":"112","author":"Kristensen J","year":"2005","unstructured":"Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005, 112:403-8. 10.1111\/j.1471-0528.2005.00437.x","journal-title":"BJOG"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000107291.46159.00","article-title":"Maternal morbid obesity and the risk of adverse pregnancy outcome","volume":"103","author":"Cedergren MI","year":"2004","unstructured":"Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004, 103:219-24. 10.1097\/01.AOG.0000107291.46159.00","journal-title":"Obstet Gynecol"},{"key":"ref36","article-title":"Obesity and Obstetrics","author":"Mahmood T","year":"2020","unstructured":"Mahmood T, Arulkumaran S, Chervenak F. Obesity and Obstetrics. Elsevier, London; 2020."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.S1.1152","article-title":"Maternal obesity and risk for birth defects","volume":"111","author":"Watkins ML","year":"2003","unstructured":"Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003, 111:1152-8. 10.1542\/peds.111.S1.1152","journal-title":"Pediatrics"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3164","article-title":"Metformin reduces maternal weight gain in obese pregnant women: a systematic review and meta-analysis of two randomized controlled trials","volume":"35","author":"D'Ambrosio V","year":"2019","unstructured":"D'Ambrosio V, Brunelli R, Vena F, et al.. Metformin reduces maternal weight gain in obese pregnant women: a systematic review and meta-analysis of two randomized controlled trials. Diabetes Metab Res Rev. 2019, 35:e3164. 10.1002\/dmrr.3164","journal-title":"Diabetes Metab Res Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki A","year":"2016","unstructured":"Syngelaki A, Nicolaides KH, Balani J, et al.. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016, 374:434-43. 10.1056\/NEJMoa1509819","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/iox164","article-title":"Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with higher endocannabinoid levels","volume":"98","author":"Sun X","year":"2018","unstructured":"Sun X, Tavenier A, Deng W, Leishman E, Bradshaw HB, Dey SK. Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with higher endocannabinoid levels. Biol Reprod. 2018, 98:208-17. 10.1093\/biolre\/iox164","journal-title":"Biol Reprod"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7100101","article-title":"Polycystic ovary syndrome in adolescence","volume":"7","author":"Deans R","year":"2019","unstructured":"Deans R. Polycystic ovary syndrome in adolescence. Med Sci (Basel). 2019, 7:10.3390\/medsci7100101","journal-title":"Med Sci (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1515\/9783110487817","article-title":"Pregnancy and Obesity","author":"Maxwell C","year":"2017","unstructured":"Maxwell C, Farine D. Pregnancy and Obesity. De Gruyter, Berlin; 2017. 10.1515\/9783110487817"},{"key":"ref43","article-title":"","author":"Dunning AM T","unstructured":"Dunning AM T. Care of People with Diabetes: A Manual of Nursing Practice. 1st ed. Wiley-Blackwell, New York; https:\/\/www.wiley.com\/en-us\/Care+of+People+with+Diabetes%3A+A+Manual+of+Nursing+Practice%2C+2nd+Edition-p-9781405151863."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba S","year":"2015","unstructured":"Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015, 21:575-92. 10.1093\/humupd\/dmv029","journal-title":"Hum Reprod Update"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev265","article-title":"Placental characteristics in women with polycystic ovary syndrome","volume":"30","author":"Koster MP","year":"2015","unstructured":"Koster MP, de Wilde MA, Veltman-Verhulst SM, Houben ML, Nikkels PG, van Rijn BB, Fauser BC. Placental characteristics in women with polycystic ovary syndrome. Hum Reprod. 2015, 30:2829-37. 10.1093\/humrep\/dev265","journal-title":"Hum Reprod"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler JE","year":"2008","unstructured":"Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008, 358:47-54. 10.1056\/NEJMct0707092","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a meta-analysis","volume":"111","author":"Creanga AA","year":"2008","unstructured":"Creanga AA, Bradley HM, McCormick C, Witkop CT. Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstet Gynecol. 2008, 111:959-68. 10.1097\/AOG.0b013e31816a4ed4","journal-title":"Obstet Gynecol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice. Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti DB","year":"2003","unstructured":"Petitti DB. Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med. 2003, 349:1443-50. 10.1056\/NEJMcp030751","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis","volume":"86","author":"Gilbert C","year":"2006","unstructured":"Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril. 2006, 86:658-63. 10.1016\/j.fertnstert.2006.02.098","journal-title":"Fertil Steril"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00856.x","article-title":"Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?","volume":"34","author":"Nawaz FH","year":"2008","unstructured":"Nawaz FH, Khalid R, Naru T, Rizvi J. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?. J Obstet Gynaecol Res. 2008, 34:832-7. 10.1111\/j.1447-0756.2008.00856.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh109","article-title":"Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy","volume":"19","author":"Glueck CJ","year":"2004","unstructured":"Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004, 19:510-21. 10.1093\/humrep\/deh109","journal-title":"Hum Reprod"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-09718-3","article-title":"Diagnosis and Management of Polycystic Ovary Syndrome","author":"Farid NR","year":"2009","unstructured":"Farid NR, Diamanti-Kandarakis E. Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, Boston; 2009. 10.1007\/978-0-387-09718-3"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycaemic agents in 118 diabetic pregnancies","volume":"17","author":"Hellmuth E","year":"2000","unstructured":"Hellmuth E, Damm P, M\u00f8lsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000, 17:507-11. 10.1046\/j.1464-5491.2000.00314.x","journal-title":"Diabet Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.09.010","article-title":"Use of metformin in polycystic ovary syndrome","volume":"199","author":"Mathur R","year":"2008","unstructured":"Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol. 2008, 199:596-609. 10.1016\/j.ajog.2008.09.010","journal-title":"Am J Obstet Gynecol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212523","article-title":"Metformin in the management of diabetes during pregnancy and lactation","volume":"7","author":"Priya G","year":"2018","unstructured":"Priya G, Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context. 2018, 7:212523. 10.7573\/dic.212523","journal-title":"Drugs Context"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007939","article-title":"Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis","volume":"96","author":"Liang HL","year":"2017","unstructured":"Liang HL, Ma SJ, Xiao YN, Tan HZ. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. Medicine (Baltimore). 2017, 96:e7939. 10.1097\/MD.0000000000007939","journal-title":"Medicine (Baltimore)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02419","article-title":"Metformin Use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs","volume":"103","author":"Hanem LG","year":"2018","unstructured":"Hanem LG, Stridsklev S, J\u00fal\u00edusson PB, et al.. Metformin Use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018, 103:1612-21. 10.1210\/jc.2017-02419","journal-title":"J Clin Endocrinol Metab"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2012.712319","article-title":"Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero","volume":"72","author":"R\u00f8 TB","year":"2012","unstructured":"R\u00f8 TB, Ludvigsen HV, Carlsen SM, Vanky E. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest. 2012, 72:570-5. 10.3109\/00365513.2012.712319","journal-title":"Scand J Clin Lab Invest"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan JA","year":"2011","unstructured":"Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011, 34:2279-84. 10.2337\/dc11-0660","journal-title":"Diabetes Care"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12964","article-title":"A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months","volume":"122","author":"Ij\u00e4s H","year":"2015","unstructured":"Ij\u00e4s H, V\u00e4\u00e4r\u00e4sm\u00e4ki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG. 2015, 122:994-1000. 10.1111\/1471-0528.12964","journal-title":"BJOG"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.11.051","article-title":"Placental passage of metformin in women with polycystic ovary syndrome","volume":"83","author":"Vanky E","year":"2005","unstructured":"Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril. 2005, 83:1575-8. 10.1016\/j.fertnstert.2004.11.051","journal-title":"Fertil Steril"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1960020524","article-title":"The use of sulphonylureas biguanides and insulin in pregnancy","author":"Stowers JM","year":"1984","unstructured":"Stowers JM, Sutherland HW. The use of sulphonylureas biguanides and insulin in pregnancy. Carbohydrate Metabolism in Pregnancy and the Newborn. Churchill Livingstone, Edinburgh ; 1984. 205-20. 10.1002\/pdi.1960020524"},{"key":"ref63","article-title":"Oral hypoglycaemics in the first trimester and fetal outcome","volume":"65","author":"Coetzee EJ","year":"1984","unstructured":"Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J. 1984, 65:635-7.","journal-title":"S Afr Med J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll E","year":"2006","unstructured":"Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006, 332:1485. 10.1136\/bmj.38867.631551.55","journal-title":"BMJ"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01750.x","article-title":"Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome?","volume":"23","author":"Hughes RC","year":"2006","unstructured":"Hughes RC, Rowan JA. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome?. Diabet Med. 2006, 23:318-22. 10.1111\/j.1464-5491.2006.01750.x","journal-title":"Diabet Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro RS","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, et al.. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007, 356:551-66. 10.1056\/NEJMoa063971","journal-title":"N Engl J Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu022","article-title":"First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis","volume":"20","author":"Cassina M","year":"2014","unstructured":"Cassina M, Don\u00e0 M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update. 2014, 20:656-69. 10.1093\/humupd\/dmu022","journal-title":"Hum Reprod Update"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1683362","article-title":"Effect of a high-fat diet and metformin on placental mTOR signaling in mice","volume":"9","author":"Grace MR","year":"2019","unstructured":"Grace MR, Dotters-Katz SK, Zhou C, Manuck T, Boggess K, Bae-Jump V. Effect of a high-fat diet and metformin on placental mTOR signaling in mice. AJP Rep. 2019, 9:e138-43. 10.1055\/s-0039-1683362","journal-title":"AJP Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109567-a-review-on-the-use-of-metformin-in-pregnancy-and-its-associated-fetal-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:01Z","timestamp":1707508261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109567-a-review-on-the-use-of-metformin-in-pregnancy-and-its-associated-fetal-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":68,"URL":"https:\/\/doi.org\/10.7759\/cureus.30039","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}